Cover Image
市場調查報告書

Kainos Medicine, Inc.- 產品平台分析

Kainos Medicine, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 289825
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Kainos Medicine, Inc.- 產品平台分析 Kainos Medicine, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 21 Pages
簡介

Kainos Medicine, Inc. 是總公司設立於韓國的製藥企業,正在從事針對癌症,代謝系疾病,感染疾病等所用之醫藥品的藥物研發及開發。開發平台有非核酸系逆轉印酵素抑制劑(NNRTI),三酸甘油酯合成抑制劑等。

本報告提供Kainos Medicine, Inc. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃相關等資訊。

目錄

Kainos Medicine, Inc. 的基本資料

  • Kainos Medicine, Inc. 概要
  • 主要資訊
  • 企業資料

Kainos Medicine, Inc. :R&D概要

  • 主要的治療範圍

Kainos Medicine, Inc. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Kainos Medicine, Inc. :開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Kainos Medicine, Inc. :藥物簡介

  • KM-001
  • KM-101
  • KM-301
  • KM-601

Kainos Medicine, Inc. :開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

Kainos Medicine, Inc. :開發被休止了的計劃

Kainos Medicine, Inc. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07369CDB

Summary

Global Markets Direct's, 'Kainos Medicine, Inc. - Product Pipeline Review - 2015', provides an overview of the Kainos Medicine, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kainos Medicine, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Kainos Medicine, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Kainos Medicine, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Kainos Medicine, Inc.'s pipeline products

Reasons to buy

  • Evaluate Kainos Medicine, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Kainos Medicine, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Kainos Medicine, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Kainos Medicine, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kainos Medicine, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Kainos Medicine, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Kainos Medicine, Inc. Snapshot
    • Kainos Medicine, Inc. Overview
    • Key Information
    • Key Facts
  • Kainos Medicine, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Kainos Medicine, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Kainos Medicine, Inc. - Pipeline Products Glance
    • Kainos Medicine, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Kainos Medicine, Inc. - Drug Profiles
    • KM-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • KM-101
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • KM-301
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • KM-601
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Kainos Medicine, Inc. - Pipeline Analysis
  • Kainos Medicine, Inc. - Pipeline Products by Target
  • Kainos Medicine, Inc. - Pipeline Products by Molecule Type
  • Kainos Medicine, Inc. - Pipeline Products by Mechanism of Action
  • Kainos Medicine, Inc. - Dormant Projects
  • Kainos Medicine, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Kainos Medicine, Inc., Key Information
  • Kainos Medicine, Inc., Key Facts
  • Kainos Medicine, Inc. - Pipeline by Indication, 2015
  • Kainos Medicine, Inc. - Pipeline by Stage of Development, 2015
  • Kainos Medicine, Inc. - Monotherapy Products in Pipeline, 2015
  • Kainos Medicine, Inc. - Preclinical, 2015
  • Kainos Medicine, Inc. - Discovery, 2015
  • Kainos Medicine, Inc. - Pipeline by Target, 2015
  • Kainos Medicine, Inc. - Pipeline by Molecule Type, 2015
  • Kainos Medicine, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Kainos Medicine, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Kainos Medicine, Inc. - Pipeline by Top 10 Indication, 2015
  • Kainos Medicine, Inc. - Pipeline by Stage of Development, 2015
  • Kainos Medicine, Inc. - Monotherapy Products in Pipeline, 2015
  • Kainos Medicine, Inc. - Pipeline by Top 10 Target, 2015
  • Kainos Medicine, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Kainos Medicine, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top